PeptidesWeight LossLongevitySexual Health - MenSexual Health - WomenHair RestorationAnti-ParasiticSleepHow it worksFAQAboutContactLog in
Peptide therapy · Subcutaneous injection
PrescriptionU.S. Licensed PharmacyProvider-ReviewedEvidence Explained

TB-500: a synthetic thymosin beta-4 fragment

TB-500 is a seven-amino-acid fragment based on thymosin beta-4. Laboratory research has explored actin binding and cell migration, but FDA has identified no human exposure data for TB-500 itself. Available by prescription only after provider review.

From $199 first month
$199First month, renews at $250/mo
Start Assessment
✓ U.S.-licensed providers✓ HIPAA-secure✓ Free discreet shipping✓ Ongoing care included
TB-500 product image
Mechanism and evidence

What the research says about TB-500

Mechanism education without turning preclinical findings into promises.

✓

A defined peptide fragment

TB-500 is an acetylated seven-amino-acid fragment corresponding to residues 17 to 23 of thymosin beta-4. TB-500 and full-length thymosin beta-4 are not the same substance.

✓

Actin and cell-migration research

Research on thymosin beta-4 and its fragments has explored actin binding and cell-migration pathways. Findings from the full-length protein or animal models cannot be assumed to apply to TB-500 use in humans.

✓

No identified human exposure data

FDA identified no clinical studies or human exposure data for TB-500 by any route. Human effectiveness, dosing, interactions, and long-term safety are unknown.

✓

A provider-directed protocol

A licensed provider reviews your history and medications before determining whether this compounded injectable option is appropriate and how it should be used.

About this treatment

Provider-reviewed care, built around the evidence

✓

Provider oversight

Prescribed only when a licensed provider determines it is appropriate based on your history, medications, and treatment goals.

✓

No mystery vials

When prescribed, your medication is prepared by and shipped directly from a licensed U.S. pharmacy in discreet packaging.

✓

Clear ingredient education

Each product page separates mechanism research from human evidence so the unknowns stay visible.

✓

Ongoing care included

Message your care team with questions about your protocol, refills, or side effects.

How it works

Care without the waiting room

Get started in 4 simple steps. No office visits required.

01

Start your assessment

A 5-minute online health questionnaire, no appointment, no waiting room.

02

Provider review

A licensed provider in your state reviews your history and prescribes if appropriate.

03

Pharmacy ships direct

When prescribed, your medication ships from a licensed U.S. pharmacy in discreet packaging.

04

Ongoing support

Message your care team anytime. Dose questions and refills are handled online.

FAQ

Questions about TB-500

What does the research actually show?

TB-500 has laboratory and animal research context, but FDA identified no human exposure data. Full-length thymosin beta-4 findings are not interchangeable with TB-500 evidence.

Is this medication FDA-approved?

No. This compounded medication is not FDA-approved. Compounded drugs are prepared for individual patients, and FDA does not verify their safety, effectiveness, or quality before marketing.

How do I know whether it is appropriate for me?

Complete the online assessment. A licensed provider reviews your medical history, medications, and goals before deciding whether to prescribe.

Where will I see pricing and protocol details?

Current pricing is shown on this page when a customer offer exists. Your provider-directed protocol and any additional details are confirmed during assessment and review.

Important safety informationTB-500 is available by prescription only after evaluation by a licensed provider. This compounded medication is not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. Common side effects and long-term risks have not been established because FDA identified no human exposure data. Injection-site reactions and allergic reactions are possible. FDA has raised concerns about immunogenicity, aggregation, and peptide-related impurities. Tell your provider about all medical conditions and medications. TB-500 is listed as a thymosin beta-4 derivative prohibited at all times by WADA. Individual results vary. This page is educational and is not medical advice.

Start with a provider review

Your assessment takes about 5 minutes. A licensed provider reviews your information and determines whether treatment is appropriate.

Start Assessment
Peptide therapy

Related treatments

BPC-157 product image

BPC-157

Subcutaneous injection

15 amino acids. One injectable protocol.

From $188 first month
Coming soonKPV product image

KPV

Provider-reviewed peptide protocol

Three amino acids. One alpha-MSH fragment.

Coming soon
Coming soonEpitalon product image

Epitalon

Provider-reviewed peptide protocol

Four amino acids. One synthetic peptide.

Coming soon
TB-500From $199 first month
Start Assessment